Compounds > 1-methyl-3-isobutylxanthine

1-methyl-3-isobutylxanthine and sauvagine

1-methyl-3-isobutylxanthine has been researched along with sauvagine in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Koning, HP; Huchedé, B; Jenks, BG; Roubos, EW	1
Kalin, NH; Roseboom, PH; Urben, CM	1
Abou-Samra, AB; Assil, IQ	1
Facci, L; Franceschini, D; Pangallo, M; Skaper, SD; Stevens, DA; Strijbos, PJ	1

Other Studies

4 other study(ies) available for 1-methyl-3-isobutylxanthine and sauvagine

Article	Year
Dynamics of cyclic-AMP efflux in relation to alpha-MSH secretion from melanotrope cells of Xenopus laevis. Life sciences, 1992, Volume: 51, Issue:21 Topics: 1-Methyl-3-isobutylxanthine; alpha-MSH; Amphibian Proteins; Animals; Baclofen; Calcium; Colforsin; Corticotropin-Releasing Hormone; Cyclic AMP; Dopamine; In Vitro Techniques; Peptide Hormones; Peptides; Pituitary Gland; Xenopus laevis	1992
Persistent corticotropin-releasing factor(1) receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32. Brain research. Molecular brain research, 2001, Aug-15, Volume: 92, Issue:1-2 Topics: 1-Methyl-3-isobutylxanthine; Adenylyl Cyclases; Amphibian Proteins; Bromodeoxyuridine; Carrier Proteins; Cell Differentiation; Corticotropin-Releasing Hormone; Cyclic AMP; Down-Regulation; Nerve Tissue Proteins; Neuroblastoma; Peptide Fragments; Peptide Hormones; Peptides; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Second Messenger Systems; Time Factors; Tumor Cells, Cultured; Vasoactive Intestinal Peptide	2001
N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction. American journal of physiology. Endocrinology and metabolism, 2001, Volume: 281, Issue:5 Topics: 1-Methyl-3-isobutylxanthine; Amphibian Proteins; Animals; Binding Sites; Binding, Competitive; Cell Line; Consensus Sequence; Corticotropin-Releasing Hormone; Cyclic AMP; Electrophoresis, Polyacrylamide Gel; Glycosylation; Ligands; Mice; Molecular Weight; Mutagenesis, Site-Directed; Peptide Hormones; Peptides; Radioligand Assay; Receptors, Corticotropin-Releasing Hormone; Structure-Activity Relationship; Tunicamycin; Urotensins	2001
Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. Neuropharmacology, 2003, Volume: 45, Issue:5 Topics: 1-Methyl-3-isobutylxanthine; Amphibian Proteins; Amyloid beta-Peptides; Animals; Animals, Newborn; Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Cerebellum; Cerebral Cortex; Chromatin; Chromones; Colforsin; Corticotropin-Releasing Hormone; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glycogen Synthase Kinase 3; Hippocampus; In Situ Nick-End Labeling; Inhibitory Concentration 50; L-Lactate Dehydrogenase; Mitogen-Activated Protein Kinase Kinases; Morpholines; Neurons; Neuroprotective Agents; Peptide Fragments; Peptide Hormones; Peptides; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Thionucleotides; Time Factors; Urocortins; Urotensins; Vasodilator Agents	2003